The Washington Research Foundation has named Indian-origin consultant Ankit K. Azad to its ninth cohort of Venture Analysts, adding healthcare strategy expertise to its team evaluating grant applications and early-stage startup investments.
Azad was born and raised in Kolkata, India, where he spent his early years before pursuing his higher education at the Kalinga Institute of Industrial Technology in Bhubaneswar, earning a Bachelor of Technology degree.
Prior to relocating to the United States, he spent five years as a commercial analytics consultant at ZS Associates. In that role, he advised Fortune 100 pharmaceutical clients on healthcare commercial strategy, market access, and global sales force effectiveness, developing an interest in how choices made around resourcing and pricing impact patient access to treatments worldwide.
Read: Anupa Shantaram named to Michigan Board of Pharmacy (August 31, 2026)
Currently an MBA candidate at the University of Washington’s Foster School of Business, Azad serves as vice president of operations for the Foster MBA Association’s Consulting Society.
His selection for the Washington Research Foundation cohort reflects a growing pathway for Indian Americans combining technical backgrounds, corporate consulting rigor, and advanced management studies to support non-profit innovation initiatives.
In his new part-time post with the Seattle-based foundation, Azad will work alongside venture leaders to evaluate promising scientific discoveries and health solutions originating from Washington state’s research institutions.
Read: Dr. Neel Shah named new president of Healthy Moms, Healthy Babies America (August 31, 2026)
Analysts play a key role in screening candidates for foundation grantmaking and investment opportunities while assessing whether emerging technologies possess the commercial viability needed to transition from academic laboratories into broad real-world deployment.
Launched in 2019, the WRF Venture Analyst program provides graduate students and postdoctoral researchers with hands-on immersion in entrepreneurship and technology transfer.
The five-member 2026 cohort will spend the coming year analyzing early-stage life science and technology applications, helping advance the foundation’s mission to foster economic development and public benefit across the Pacific Northwest.